Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.
about
THE EMERGENCE OF ARTHROPOD-BORNE VIRAL DISEASES: A GLOBAL PROSPECTIVE ON DENGUE, CHIKUNGUNYA AND ZIKA FEVERSHigh frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central BrazilInvestigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam.DHIM supporting immunologic investigations and the identification of immune correlates of protection.Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.How season and serotype determine dengue transmissibilityA new approach to monitoring dengue activitySeroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, MexicoSymptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionDengue seroprevalence in the French West Indies: a prospective study in adult blood donors.B-Cell Responses to Human Bocaviruses 1-4: New Insights from a Childhood Follow-Up StudyDominant cross-reactive B cell response during secondary acute dengue virus infection in humansDengue viruses cluster antigenically but not as discrete serotypesReduced risk of disease during postsecondary dengue virus infections.Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil.Seroepidemiology of dengue virus infection in the adult population in tropical Singapore.Evaluation of Commercially Available Assays for Diagnosis of Acute Dengue in Schoolchildren During an Epidemic Period in Medellin, Colombia.Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.Identification of immune correlates of protection in Shigella infection by application of machine learning.Influence of FcγRIIa-Expressing Cells on the Assessment of Neutralizing and Enhancing Serum Antibodies Elicited by a Live-Attenuated Tetravalent Dengue Vaccine.Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.Significant increase in travel-associated dengue fever in Germany.The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.Dengue seroprevalence: data from the clinical development of a tetravalent dengue vaccine in 14 countries (2005-2014).Dengue virus serotype distribution based on serological evidence in pediatric urban population in IndonesiaUsing bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitorsRisk Factors Associated with Dengue Transmission and Spatial Distribution of High Seroprevalence in Schoolchildren from the Urban Area of Medellin, Colombia
P2860
Q27901943-B268165D-4A70-456F-906D-DD3C0E18876EQ27928048-1DBE0876-2548-4AEF-B7C2-CA6ECFEF22FEQ33588528-787816F3-D871-4463-9984-B6D755AD2902Q33676842-BC6D9FB5-BE13-49E1-A3BA-CDE9F6F006CDQ33743890-4D998A89-1984-4C57-AC40-46568DD0C85DQ33853984-23BEC9BA-9828-4D63-8DC6-F83A19509E3AQ33925216-6CD33DC6-3E28-4444-9EC2-0408AAE30E97Q34496118-7C721054-C574-4082-9385-DB7DDC681A3EQ34952330-C3F748F6-E637-4CF4-92DC-90B720EFBDA6Q35601805-D268D756-92B5-4460-8EE0-5EC9442DE894Q35692475-60F8B24B-CFAF-4E12-8F7E-3F50AE4A34D1Q35791624-7275B381-1554-4E4B-9444-600C11D43B94Q35842365-FA267CED-0389-4A43-BC98-3EAD3B508BC3Q36926525-8EF67341-1CD0-44B1-99D2-4DF83E7CBAE6Q37109553-146D1121-6EC3-4C97-98F9-DE7B9EA6016EQ37372595-DBC4D08E-FB68-4CEF-87BE-12BAB9A55A44Q38875598-A021FE7A-D4A5-4241-95F2-B2DC43FE8447Q39355556-38F26772-D51F-4092-8458-085B5841590FQ40095659-78314E14-2515-49E9-A429-3276B621FA11Q40095911-8E99F283-8AB1-46A0-AF58-4C88B629B98FQ40124689-57654E5F-E4BB-44EF-8DE7-AD9AA452FB82Q40238069-5F0649C9-9296-44D3-80D0-BF42224B4344Q40334431-FAB843CC-3C45-42BC-8D68-F6CDEAB38C91Q51782689-7B8D8F87-9E98-4E35-A607-64ABE911EF20Q55046089-F4A11A13-553C-4066-84FB-8F1631ECDE5FQ56476041-12663DF8-1756-4003-9F51-1074667A7E05Q57070027-6B33B031-77EC-45B8-A8BB-B28837A8557CQ58770138-964C4F23-4C97-4EBE-9997-3EC5CC9725C9
P2860
Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inferring the serotype associa ...... neutralizing antibody titers.
@ast
Inferring the serotype associa ...... neutralizing antibody titers.
@en
Inferring the serotype associa ...... neutralizing antibody titers.
@nl
type
label
Inferring the serotype associa ...... neutralizing antibody titers.
@ast
Inferring the serotype associa ...... neutralizing antibody titers.
@en
Inferring the serotype associa ...... neutralizing antibody titers.
@nl
prefLabel
Inferring the serotype associa ...... neutralizing antibody titers.
@ast
Inferring the serotype associa ...... neutralizing antibody titers.
@en
Inferring the serotype associa ...... neutralizing antibody titers.
@nl
P2093
P2860
P50
P356
P1476
Inferring the serotype associa ...... neutralizing antibody titers.
@en
P2093
Alan L Rothman
Anon Srikiatkhachorn
Donald S Burke
Robert V Gibbons
Timothy P Endy
P2860
P304
P356
10.1086/656141
P407
P577
2010-10-01T00:00:00Z